#METABOLOMICS WORKBENCH epannkuk_20190228_054732 DATATRACK_ID:1656 STUDY_ID:ST001160 ANALYSIS_ID:AN001918 VERSION 1 CREATED_ON 03-03-2022 #PROJECT PR:PROJECT_TITLE Nonhuman primate (NHP) radiation metabolomics PR:PROJECT_SUMMARY Here, we use global metabolomics to differentiate temporal effects (1 – 60 d) PR:PROJECT_SUMMARY found in nonhuman primate (NHP) urine small molecule signatures after a 4 Gy PR:PROJECT_SUMMARY total body irradiation. PR:INSTITUTE Georgetown University PR:LAST_NAME Pannkuk PR:FIRST_NAME Evan PR:ADDRESS 3970 Reservoir Rd, NW New Research Build, washington dc, District of Columbia, PR:ADDRESS 20057, USA PR:EMAIL elp44@georgetown.edu PR:PHONE 2026875650 PR:DOI http://dx.doi.org/10.21228/M8P09H #STUDY ST:STUDY_TITLE Targeted NHP serum metabolomics (part-III) ST:STUDY_SUMMARY Here, we use global metabolomics to differentiate temporal effects (1 – 60 d) ST:STUDY_SUMMARY found in nonhuman primate (NHP) serum small molecule signatures after a 4 Gy ST:STUDY_SUMMARY total body irradiation. ST:INSTITUTE Georgetown University ST:LAST_NAME Pannkuk ST:FIRST_NAME Evan ST:ADDRESS 3970 Reservoir Rd, NW New Research Build ST:EMAIL elp44@georgetown.edu ST:PHONE 2026875650 ST:SUBMIT_DATE 2019-02-28 #SUBJECT SU:SUBJECT_TYPE Mammal SU:SUBJECT_SPECIES Macaca mulatta SU:TAXONOMY_ID 9544 #SUBJECT_SAMPLE_FACTORS: SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data SUBJECT_SAMPLE_FACTORS - NHP25 Treatment:control_training SUBJECT_SAMPLE_FACTORS - NHP26 Treatment:control_training SUBJECT_SAMPLE_FACTORS - NHP27 Treatment:control_training SUBJECT_SAMPLE_FACTORS - NHP28 Treatment:control_training SUBJECT_SAMPLE_FACTORS - NHP29 Treatment:control_training SUBJECT_SAMPLE_FACTORS - NHP30 Treatment:control_training SUBJECT_SAMPLE_FACTORS - NHP31 Treatment:control_training SUBJECT_SAMPLE_FACTORS - NHP32 Treatment:control_training SUBJECT_SAMPLE_FACTORS - NHP33 Treatment:control_training SUBJECT_SAMPLE_FACTORS - NHP34 Treatment:control_training SUBJECT_SAMPLE_FACTORS - NHP35 Treatment:control_training SUBJECT_SAMPLE_FACTORS - NHP36 Treatment:control_training SUBJECT_SAMPLE_FACTORS - NHP1 Treatment:control_validation SUBJECT_SAMPLE_FACTORS - NHP10 Treatment:control_validation SUBJECT_SAMPLE_FACTORS - NHP11 Treatment:control_validation SUBJECT_SAMPLE_FACTORS - NHP12 Treatment:control_validation SUBJECT_SAMPLE_FACTORS - NHP13 Treatment:control_validation SUBJECT_SAMPLE_FACTORS - NHP14 Treatment:control_validation SUBJECT_SAMPLE_FACTORS - NHP15 Treatment:control_validation SUBJECT_SAMPLE_FACTORS - NHP16 Treatment:control_validation SUBJECT_SAMPLE_FACTORS - NHP2 Treatment:control_validation SUBJECT_SAMPLE_FACTORS - NHP3 Treatment:control_validation SUBJECT_SAMPLE_FACTORS - NHP4 Treatment:control_validation SUBJECT_SAMPLE_FACTORS - NHP5 Treatment:control_validation SUBJECT_SAMPLE_FACTORS - NHP6 Treatment:control_validation SUBJECT_SAMPLE_FACTORS - NHP7 Treatment:control_validation SUBJECT_SAMPLE_FACTORS - NHP8 Treatment:control_validation SUBJECT_SAMPLE_FACTORS - NHP9 Treatment:control_validation SUBJECT_SAMPLE_FACTORS - NHP37 Treatment:exp_training SUBJECT_SAMPLE_FACTORS - NHP38 Treatment:exp_training SUBJECT_SAMPLE_FACTORS - NHP39 Treatment:exp_training SUBJECT_SAMPLE_FACTORS - NHP40 Treatment:exp_training SUBJECT_SAMPLE_FACTORS - NHP41 Treatment:exp_training SUBJECT_SAMPLE_FACTORS - NHP42 Treatment:exp_training SUBJECT_SAMPLE_FACTORS - NHP43 Treatment:exp_training SUBJECT_SAMPLE_FACTORS - NHP44 Treatment:exp_training SUBJECT_SAMPLE_FACTORS - NHP45 Treatment:exp_training SUBJECT_SAMPLE_FACTORS - NHP46 Treatment:exp_training SUBJECT_SAMPLE_FACTORS - NHP47 Treatment:exp_training SUBJECT_SAMPLE_FACTORS - NHP48 Treatment:exp_training SUBJECT_SAMPLE_FACTORS - NHP17 Treatment:exp_validation SUBJECT_SAMPLE_FACTORS - NHP18 Treatment:exp_validation SUBJECT_SAMPLE_FACTORS - NHP19 Treatment:exp_validation SUBJECT_SAMPLE_FACTORS - NHP20 Treatment:exp_validation SUBJECT_SAMPLE_FACTORS - NHP21 Treatment:exp_validation SUBJECT_SAMPLE_FACTORS - NHP22 Treatment:exp_validation SUBJECT_SAMPLE_FACTORS - NHP23 Treatment:exp_validation SUBJECT_SAMPLE_FACTORS - NHP24 Treatment:exp_validation #COLLECTION CO:COLLECTION_SUMMARY None CO:SAMPLE_TYPE Blood (serum) #TREATMENT TR:TREATMENT_SUMMARY 4 Gy at 0.6 Gy/min with a 60Co γ source #SAMPLEPREP SP:SAMPLEPREP_SUMMARY Serum (5 μl) was diluted with 200 μl cold methanol:acetonitrile:water SP:SAMPLEPREP_SUMMARY (80:15:5) spiked with internal standards, vortexed, placed on ice for 10 min, SP:SAMPLEPREP_SUMMARY and centrifuged for 10 min (10,000 x g, 4°C) #CHROMATOGRAPHY CH:INSTRUMENT_NAME Waters ACQUITY UPLC CH:COLUMN_NAME Acquity BEH amide 1.7 μm 2.1 x 100 mm CH:CHROMATOGRAPHY_TYPE HILIC #ANALYSIS AN:ANALYSIS_TYPE MS #MS MS:INSTRUMENT_NAME Waters Xevo-TQ-S MS:INSTRUMENT_TYPE Triple quadrupole MS:MS_TYPE ESI MS:MS_COMMENTS None MS:ION_MODE UNSPECIFIED #MS_METABOLITE_DATA MS_METABOLITE_DATA:UNITS ng/ml MS_METABOLITE_DATA_START Samples NHP25 NHP26 NHP27 NHP28 NHP29 NHP30 NHP31 NHP32 NHP33 NHP34 NHP35 NHP36 NHP1 NHP10 NHP11 NHP12 NHP13 NHP14 NHP15 NHP16 NHP2 NHP3 NHP4 NHP5 NHP6 NHP7 NHP8 NHP9 NHP37 NHP38 NHP39 NHP40 NHP41 NHP42 NHP43 NHP44 NHP45 NHP46 NHP47 NHP48 NHP17 NHP18 NHP19 NHP20 NHP21 NHP22 NHP23 NHP24 Factors Treatment:control_training Treatment:control_training Treatment:control_training Treatment:control_training Treatment:control_training Treatment:control_training Treatment:control_training Treatment:control_training Treatment:control_training Treatment:control_training Treatment:control_training Treatment:control_training Treatment:control_validation Treatment:control_validation Treatment:control_validation Treatment:control_validation Treatment:control_validation Treatment:control_validation Treatment:control_validation Treatment:control_validation Treatment:control_validation Treatment:control_validation Treatment:control_validation Treatment:control_validation Treatment:control_validation Treatment:control_validation Treatment:control_validation Treatment:control_validation Treatment:exp_training Treatment:exp_training Treatment:exp_training Treatment:exp_training Treatment:exp_training Treatment:exp_training Treatment:exp_training Treatment:exp_training Treatment:exp_training Treatment:exp_training Treatment:exp_training Treatment:exp_training Treatment:exp_validation Treatment:exp_validation Treatment:exp_validation Treatment:exp_validation Treatment:exp_validation Treatment:exp_validation Treatment:exp_validation Treatment:exp_validation carnitine 27.1000 47.4000 15.2000 29.1000 33.7000 9.2000 24.7000 28.8000 10.4000 7.7000 9.8000 10.8000 33.7000 19.2000 2.4000 24.9000 15.3000 17.7000 58.0000 3.9000 4.0000 9.9000 27.0000 22.6000 12.8000 7.8000 44.7000 16.1000 16.8000 19.4000 34.8000 26.5000 26.2000 29.1000 27.7000 27.4000 51.9000 76.3000 52.2000 53.9000 41.3000 45.6000 70.8000 14.1000 41.2000 25.1000 13.1000 hypoxanthine 11.9000 13.8000 8.8000 18.7000 10.5000 16.4000 17.5000 9.7000 10.7000 12.0000 13.4000 8.9000 13.5000 12.6000 11.6000 9.4000 10.4000 14.9000 15.0000 9.7000 13.9000 13.2000 8.7000 15.1000 19.0000 10.8000 8.2000 11.9000 2.1000 8.8000 4.5000 5.4000 0.4000 1.5000 2.0000 3.2000 5.9000 4.5000 9.1000 4.3000 4.3000 11.0000 6.2000 2.4000 4.8000 6.9000 4.1000 taurine 70.8000 99.4000 63.5000 102.8000 120.5000 91.1000 132.0000 88.4000 103.2000 79.8000 78.6000 52.3000 59.7000 61.6000 69.2000 52.5000 75.6000 65.4000 72.9000 86.6000 56.1000 91.3000 59.6000 74.2000 93.4000 60.7000 72.6000 63.4000 40.5000 59.0000 41.9000 43.9000 33.0000 38.9000 27.4000 35.4000 47.3000 57.3000 45.4000 47.6000 61.9000 38.0000 54.7000 43.8000 26.7000 74.9000 43.0000 MS_METABOLITE_DATA_END #METABOLITES METABOLITES_START metabolite_name pubchem_id inchi_key kegg_id other_id other_id_type ri ri_type moverz_quant carnitine hypoxanthine taurine METABOLITES_END #END